Assignee
PRETZEL THERAPEUTICS INC
US·0 granted patents·11 pending applications·0 citations·filing 2022–2025
Top patents by PatentIndex Score
11 records- 0182US2025051367A1Heterocycle-containing lonp1 inhibitor compounds, uses and methodsPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0281US2025059213A1Lonp1 inhibitors, uses and methodsPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0381US2025320234A1Lonp1 inhibitor compounds, uses and methodsPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0481US2025059214A1Amide-containing lonp1 inhibitor compounds, uses and methodsPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0562US2025066377A1Amino chromen-2-one modulators of polrmtPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0661US2024368106A1Hydroxy and alkoxy coumarins as modulators of polrmtPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0761US2024391875A1Isoquinolinones and quinolinones as modulators of polrmtPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0861US2025326732A1Chromen-2-one modulators of polrmtPRETZEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0955US2026070888A17-alkoxyquinolines as modulators of polrmtPRETZEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1055US2025353816A1Quinolines as modulators of polrmtPRETZEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1155US2025340516A1Isoquinolinones as Modulators of POLRMTPRETZEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PRETZEL THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →